CEP55 and hepatocellular carcinoma: Several studies have reported that molecular-based stratification of HCC could identify disease subtypes with differential outcomes (Lee et al., 2004; Boyault et al., 2007; Hoshida et al., 2009), and the relationships between CEP55 expression and these subtypes were analyzed.